Novelos Therapeutics

Novelos Therapeutics Closes $5.4 Million Public Offering
Yahoo
Thu, 06/14/12 - 01:21 pm
Novelos Therapeutics
stock offering
The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
clinical trials
dimebon
Medivation
Pfizer
ocrelizumab
Roche
rheumatoid arthritis
taspoglutide
diabetes
Ipsen
semagacestat
Eli Lilly
ASA404
Antisoma
Novartis
Novelos Therapeutics
AstraZeneca
zibotentan
vicriviroc
Merck
Recentin
Vical
Sanofi
Drug Pipeline Pulse Check: High Expectations for Novartis
Seeking Alpha
Mon, 07/12/10 - 02:38 pm
Novartis
Genzyme
Novelos Therapeutics
Alcon
Novelos cancels lung-cancer drug project
Bizjournals.com
Fri, 03/19/10 - 08:59 am
Novelos Therapeutics
lung cancer
Brower Piven Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Novelos Therapeutics, Inc. to Inquire About the Lead Plaintiff Position
MarketWire
Sat, 03/13/10 - 10:21 am
Novelos Therapeutics
lawsuits
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Mon, 03/8/10 - 10:23 am
Alkermes
Amylin
MannKind
Cell Therapeutics
Dendreon
Isis Pharmaceuticals
Amag Pharmaceuticals
XenoPort
Novelos Therapeutics
Adventrx
Delcath
The Egleston Law Firm and Rigrodsky & Long, P.A. File Class Action Suit Against Novelos Therapeutics, Inc.
Yahoo/Global NewsWire
Sat, 03/6/10 - 12:33 pm
Novelos Therapeutics
lawsuits
Biotech Stock Mailbag: BioSante Pharma
TheStreet.com
Fri, 02/26/10 - 09:20 am
BioSante
Proctor & Gamble
Novelos Therapeutics
InterMune
ARYx
Health Discovery
Xoma
Novelos Therapeutics Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint
Marketwatch
Wed, 02/24/10 - 10:23 am
Novelos Therapeutics
lung cancer
10 Biotech Stocks on Clinical Trials Watch
TheStreet.com
Thu, 02/4/10 - 10:30 am
Vertex Pharmaceuticals
Optimer
Novelos Therapeutics
Medivation
Isis Pharmaceuticals
Genzyme
GenVec
Delcath
Amgen
Allos
Affymax
Digging Deeper into Adventrx Pharmaceuticals
TheStreet.com
Tue, 01/19/10 - 09:40 am
Adventrx
Genentech
Novartis
Amgen
Pfizer
Novelos Therapeutics
ONYX Pharmaceuticals
Biotech Stock Mailbag: Adventrx Pharmaceuticals
TheStreet.com
Fri, 01/15/10 - 09:23 am
Cord Blood America
Adventrx
Novelos Therapeutics
MannKind
Hemispherx
Cell Therapeutics
Novelos Therapeutics Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial
Trading Markets
Sat, 01/9/10 - 12:50 pm
Novelos Therapeutics
lung cancer
Biotech Stock Mailbag: Novelos Therapeutics and more
TheStreet.com
Fri, 01/8/10 - 11:23 am
Poniard
Novelos Therapeutics
MannKind
Dendreon
Cell Therapeutics
BioDelivery Sciences
Biocryst
Novelos CEO: Very Bullish About Upcoming Pivotal Phase III Results
Seeking Alpha
Thu, 12/17/09 - 09:31 am
Novelos Therapeutics
clinical trials
lung cancer
Novelos Therapeutics Secures $9 Million Private Placement
Trading Markets
Sat, 08/29/09 - 11:23 am
Novelos Therapeutics
Purdue
Biotech Mailbag: No Stem-Cell Gold Mine
TheStreet.com
Fri, 02/27/09 - 08:07 am
stem cells
biotech
Geron
Advanced Cell Technologies
Novelos Therapeutics
Genentech